Flisiak, Robert https://orcid.org/0000-0003-3394-1635
Zarębska-Michaluk, Dorota
Rogalska, Magdalena
Kryńska, Justyna Anna
Kowalska, Justyna
Dutkiewicz, Ewa
Dobrowolska, Krystyna
Jaroszewicz, Jerzy
Moniuszko-Malinowska, Anna
Rorat, Marta
Podlasin, Regina
Tronina, Olga
Rzymski, Piotr
Funding for this research was provided by:
Polskie Towarzystwo Epidemiologów i Lekarzy Chorób Zakaźnych
Article History
Received: 28 June 2022
Revised: 12 August 2022
Accepted: 17 August 2022
First Online: 24 August 2022
Change Date: 3 October 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s43440-022-00419-3
Declarations
:
: Robert Flisiak and Jerzy Jaroszewicz reports grants and personal fees from MSD, Gilead, and Roche; Dorota Zarębska-Michaluk reports personal fees from MSD and Gilead; Justyna Kowalska reports grants and personal fees from MSD, Gilead, Janssen Cilag, GSK/ViiV and Roche; Anna Moniuszko-Malinowska reports personal fee from DiaSorin; Regina Podlasin reports personal fees from Gilead; Magdalena Rogalska, Justyna Anna Kryńska, Ewa Dutkiewicz, Krystyna Dobrowolska, Marta Rorat, Olga Tronina, Piotr Rzymski report no financial interests in relation to the work described.